Skip to main content

Advertisement

ADVERTISEMENT

News

News
05/18/2023
vMap’s use with ‘Unmappable’ Ventricular Tachycardia Ablation and Accurate Proof-of-Concept Mapping Using Outpatient 12-lead ECG Data to be Presented at the Heart Rhythm Society’s Annual Conference in New Orleans.
vMap’s use with ‘Unmappable’ Ventricular Tachycardia Ablation and Accurate Proof-of-Concept Mapping Using Outpatient 12-lead ECG Data to be Presented at the Heart Rhythm Society’s Annual Conference in New Orleans.
vMap’s use with ‘Unmappable’...
05/18/2023
EP Lab Digest
News
05/16/2023
Visit Booth #2135 to Learn How Integer’s Strategic Growth and Innovation in Medical Device Manufacturing, Design and Development Capabilities Meets Customers’ Evolving Medtech Needs.
Visit Booth #2135 to Learn How Integer’s Strategic Growth and Innovation in Medical Device Manufacturing, Design and Development Capabilities Meets Customers’ Evolving Medtech Needs.
Visit Booth #2135 to Learn How...
05/16/2023
EP Lab Digest

Advertisement

News
05/16/2023
AccuRhythm AI algorithms now cleared by FDA for the Reveal LINQ ICM; enhancements made to the AF algorithm for the LINQ II ICM
AccuRhythm AI algorithms now cleared by FDA for the Reveal LINQ ICM; enhancements made to the AF algorithm for the LINQ II ICM
AccuRhythm AI algorithms now...
05/16/2023
EP Lab Digest
News
05/16/2023
Data Presented at Heart Rhythm Conference Will Highlight Importance of High-Fidelity, Low-Noise ECG Signals
Data Presented at Heart Rhythm Conference Will Highlight Importance of High-Fidelity, Low-Noise ECG Signals
Data Presented at Heart Rhythm...
05/16/2023
EP Lab Digest
News
05/16/2023
• The OCEANIC-AF (atrial fibrillation) study with asundexian is part of the Phase III OCEANIC clinical trial program enrolling more than 27,000 patients in over 40 countries • Asundexian is being evaluated as a potential improved treatment...
• The OCEANIC-AF (atrial fibrillation) study with asundexian is part of the Phase III OCEANIC clinical trial program enrolling more than 27,000 patients in over 40 countries • Asundexian is being evaluated as a potential improved treatment...
• The OCEANIC-AF (atrial...
05/16/2023
EP Lab Digest

Advertisement

News
05/15/2023
Momentum Continues as Depth of Clinical Experience Expands Worldwide
Momentum Continues as Depth of Clinical Experience Expands Worldwide
Momentum Continues as Depth of...
05/15/2023
EP Lab Digest
News
05/15/2023
The longest-running and leading event for electrophysiologists heads to New Orleans to share agenda-setting science and innovation.
The longest-running and leading event for electrophysiologists heads to New Orleans to share agenda-setting science and innovation.
The longest-running and leading...
05/15/2023
EP Lab Digest
News
05/15/2023
Acutus Medical, Inc. is pleased to announce its participation in the upcoming Heart Rhythm Society (HRS) Annual Scientific Sessions in New Orleans, LA, from May 19-21, 2023.
Acutus Medical, Inc. is pleased to announce its participation in the upcoming Heart Rhythm Society (HRS) Annual Scientific Sessions in New Orleans, LA, from May 19-21, 2023.
Acutus Medical, Inc. is pleased...
05/15/2023
EP Lab Digest

Advertisement

News
05/09/2023
-Anticoagulant Bleeding Burden Adherence Confidence Assessment Scale [ABBA-CAS] Created to Better Address an Important Treatment Gap in the Management of Atrial Fibrillation (AF) and Bring Patient Issues to the Forefront -Developed with...
-Anticoagulant Bleeding Burden Adherence Confidence Assessment Scale [ABBA-CAS] Created to Better Address an Important Treatment Gap in the Management of Atrial Fibrillation (AF) and Bring Patient Issues to the Forefront -Developed with...
-Anticoagulant Bleeding Burden...
05/09/2023
EP Lab Digest
News
05/09/2023
Leading physicians from Cleveland Clinic to present data from three posters that showcase the Company’s novel PURE EP™ Platform.
Leading physicians from Cleveland Clinic to present data from three posters that showcase the Company’s novel PURE EP™ Platform.
Leading physicians from...
05/09/2023
EP Lab Digest

Advertisement